Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
- Peter Lynch
Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease.
Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
---|---|---|---|---|---|---|---|
2021-02-22 | Crowley John F | Chairman & CEO | Sell | 7,682 | $11.98 | $92,027 | No |
2021-02-16 | Crowley John F | Chairman & CEO | Sell | 22,000 | $12.26 | $269,700 | Yes |
2021-02-01 | WHITMAN BURKE W | Director | Buy | 1,500 | $19.09 | $28,637 | No |
2021-02-01 | Crowley John F | Chairman & CEO | Sell | 7,500 | $19.08 | $143,077 | No |
2021-02-01 | Campbell Bradley L | Chief Operating Officer | Sell | 10,514 | $19.08 | $200,571 | Yes |
2021-01-20 | Crowley John F | Chairman & CEO | Sell | 72,000 | $21.73 | $1,564,693 | Yes |
2021-01-04 | Crowley John F | Chairman & CEO | Sell | 7,500 | $22.17 | $166,305 | Yes |
2021-01-04 | Campbell Bradley L | Chief Operating Officer | Sell | 10,514 | $22.17 | $233,125 | Yes |
2021-01-04 | WHITMAN BURKE W | Director | Buy | 1,500 | $23.17 | $34,755 | No |
2020-12-21 | Quimi Daphne | Chief Financial Officer | Sell | 5,000 | $24.09 | $120,474 | Yes |
2020-12-15 | Crowley John F | Chairman & CEO | Sell | 22,000 | $23.91 | $526,101 | Yes |
2020-12-14 | Do Hung | Chief Science Officer | Sell | 111,125 | $23.88 | $2,653,276 | No |
2020-12-01 | WHITMAN BURKE W | Director | Buy | 1,500 | $23.50 | $35,250 | No |
2020-12-01 | Crowley John F | Chairman & CEO | Sell | 7,500 | $22.77 | $170,776 | No |
2020-12-01 | Campbell Bradley L | Chief Operating Officer | Sell | 24,783 | $22.77 | $564,192 | Yes |
2020-11-04 | Prout Samantha | Principal Accounting Officer | Sell | 5,931 | $20.00 | $118,620 | Yes |
2020-11-02 | WHITMAN BURKE W | Director | Buy | 1,500 | $18.01 | $27,015 | No |
2020-11-02 | Crowley John F | Chairman & CEO | Sell | 33,875 | $17.87 | $605,272 | Yes |
2020-11-02 | Campbell Bradley L | Chief Operating Officer | Sell | 24,782 | $17.87 | $442,792 | Yes |
2020-10-09 | Do Hung | Chief Science Officer | Sell | 193,700 | $15.03 | $2,911,272 | Yes |
2020-10-01 | WHITMAN BURKE W | Director | Buy | 1,500 | $14.28 | $21,413 | No |
2020-10-01 | Crowley John F | Chairman & CEO | Sell | 29,900 | $14.02 | $419,105 | Yes |
2020-10-02 | Quimi Daphne | Chief Financial Officer | Sell | 5,000 | $14.02 | $70,099 | Yes |
2020-09-30 | Barth Jay | Chief Medical Officer | Sell | 4,064 | $14.51 | $58,951 | Yes |
2020-09-28 | Campbell Bradley L | Chief Operating Officer | Sell | 24,782 | $13.89 | $344,205 | Yes |
2020-09-01 | WHITMAN BURKE W | Director | Buy | 1,500 | $14.62 | $21,930 | No |
2020-09-01 | Crowley John F | Chairman & CEO | Sell | 29,900 | $14.18 | $423,850 | Yes |
2020-08-31 | Barth Jay | Chief Medical Officer | Sell | 28,750 | $14.74 | $423,746 | Yes |
2020-08-17 | Crowley John F | Chairman & CEO | Sell | 20,000 | $14.89 | $297,814 | Yes |
2020-08-05 | Prout Samantha | Principal Accounting Officer | Sell | 198 | $15.05 | $2,980 | Yes |
Insider Smart
Insider Smart